These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32557449)

  • 1. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
    Levi M; Thachil J
    Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
    Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
    J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
    Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
    Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
    [No Abstract]   [Full Text] [Related]  

  • 9. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
    Thachil J
    J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis.
    Thachil J; Lisman T
    Semin Thromb Hemost; 2020 Oct; 46(7):831-834. PubMed ID: 32882717
    [No Abstract]   [Full Text] [Related]  

  • 12. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
    Rodriguez-Sevilla JJ; Rodó-Pin A; Espallargas I; Villar-García J; Molina L; Pérez Terán P; Vázquez Sanchez A; Masclans JR; Jiménez C; Millan Segovia R; Zuccarino F; Salar A; Rodriguez-Chiaradía DA
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):758-759. PubMed ID: 32773301
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
    Thachil J; Srivastava A
    Semin Thromb Hemost; 2020 Oct; 46(7):777-780. PubMed ID: 32396963
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and COVID-19.
    Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
    Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
    [No Abstract]   [Full Text] [Related]  

  • 18. Poor Outcome of Intestinal Ischemic Manifestations of COVID-19.
    Norsa L; Bonaffini PA; Indriolo A; Valle C; Sonzogni A; Sironi S
    Gastroenterology; 2020 Oct; 159(4):1595-1597.e1. PubMed ID: 32569772
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.